Trending...
- Trump's Executive Order Rescheduling Cannabis: Accelerating M&A in a Multibillion-Dollar Industry
- A Well-Fed World, Youth Climate Save and PAN International Launch PHRESH: A Global Directory of Plant-Based Hunger Relief Organizations
- HBZBZL Unveils "Intelligent Ecosystem" Strategy: Integrating AI Analytics with Web3 Incubation
CARTHAGE, Mo. - PrAtlas -- Stratum Nutrition®, (a business of ESM Technologies), in conjunction with Blis Technologies, is pleased to announce the release of dairy-free BLIS K12® and BLIS M18® to Stratum Nutrition's ingredient science-backed portfolio. Stratum Nutrition is the North American distributor for Blis Technologies. The release of both allergen free ingredients is helpful to customers seeking to formulate dairy free, probiotic lines. Strains are available today to customers with appropriate equivalency data.
Brian Watson, CEO at Blis Technologies said, "We are pleased to offer Stratum customers Dairy Free versions of BLIS K12® and BLIS M18® recognizing that a proportion of consumers may have had allergens to dairy that have prevented them from accessing our probiotic strains. We have partnered with Sacco System, a probiotic fermentation expert, to develop these versions of the strains and provide ongoing supply. It is important to note that we will continue to offer the original versions of both BLIS K12® and BLIS M18® that have been trusted by a wide range of customers over many years."
Blis Technologies has been the scientific leader in oral probiotics since 2002 and they continue to lead the way in oral probiotic supplements. When it comes to a healthy oral cavity, Streptococcus salivarius is the dominant organism present and several strains have been shown to produce favorable bacteriocin-like inhibitory substances (BLIS). Two strains are currently marketed as probiotic ingredients, BLIS K12® and BLIS M18®.
More on PrAtlas
BLIS K12® helps maintain ear, nose, and throat health and supports our natural immune system defenses.* It is safe and effective for children and adults and features a robust research portfolio with over 30 years of published research. BLIS M18® is a friendly bacteria that can be used in conjunction with regular oral hygiene practices to establish a healthy balance of natural bacteria in the mouth to support healthy teeth and gums and overall health.
Micah Osborne, CEO at Stratum Nutrition®, "We are proud to be partnered with Blis Technologies as they continue to pursue research to provide high quality probiotic solutions. The BLIS ingredients have been a key part of our proprietary branded ingredient portfolio. We are excited to be able to build on this with the addition of dairy free BLIS K12® and BLIS M18®."
For more information about Stratum Nutrition® and its branded ingredients, please visit www.stratumnutrition.com.
###
About Stratum Nutrition
Stratum Nutrition®, a business of ESM Technologies, LLC, sustainably provides world class nutrition ingredient solutions to nutritional product formulators for human and pet health. Stratum offers a portfolio of research-supported, branded ingredients that are progressive, safe and effective, including NEM® brand eggshell membrane, ESC® brand eggshell calcium, Ahiflower® plant-based omegas-3,6,9, Curcumin 95, curQplus™, LBiome™ Lactobacillus LB postbiotic, NatAxtin™ astaxanthin, as well as oral health probiotics, BLIS K12® and BLIS M18®. These trusted ingredients are relied upon by consumers internationally. Visit www.stratumnutrition.com for more information.
More on PrAtlas
About Blis Technologies
Blis Technologies develops and manufactures the world's first advanced oral probiotics, BLIS K12® & BLIS M18®. Based out of New Zealand, Blis Technologies combine innovation with more than 30 years of research to provide delivery probiotic solutions for specific health areas including ears, nose, throat, teeth and gums, and skin care. Visit www.blis.co.nz for more information.
Brian Watson, CEO at Blis Technologies said, "We are pleased to offer Stratum customers Dairy Free versions of BLIS K12® and BLIS M18® recognizing that a proportion of consumers may have had allergens to dairy that have prevented them from accessing our probiotic strains. We have partnered with Sacco System, a probiotic fermentation expert, to develop these versions of the strains and provide ongoing supply. It is important to note that we will continue to offer the original versions of both BLIS K12® and BLIS M18® that have been trusted by a wide range of customers over many years."
Blis Technologies has been the scientific leader in oral probiotics since 2002 and they continue to lead the way in oral probiotic supplements. When it comes to a healthy oral cavity, Streptococcus salivarius is the dominant organism present and several strains have been shown to produce favorable bacteriocin-like inhibitory substances (BLIS). Two strains are currently marketed as probiotic ingredients, BLIS K12® and BLIS M18®.
More on PrAtlas
- The 22% Tax Reality: Finland's New Gambling Law Creates a "Fiscal Trap" for Grey Market Casino Players
- Phinge Founder & CEO Robert DeMaio Ranked #1 Globally on Crunchbase, Continues to Convert Previous Debt Owed to Him by Phinge into Convertible Notes
- Donna Cardellino Manager/Facilitator Signs Justin Jeansonne Country Singer-Songwriter To Exclusive Management Deal For Global Music Expansion
- Golden Paper Launches a New Chapter in Its Americas Strategy- EXPOPRINT Latin America 2026 in Brazil
- UK Financial Ltd Executes Compliance Tasks Ahead Of First-Ever ERC-3643 Exchange-Traded Token, SMCAT & Sets Date For Online Investor Governance Vote
BLIS K12® helps maintain ear, nose, and throat health and supports our natural immune system defenses.* It is safe and effective for children and adults and features a robust research portfolio with over 30 years of published research. BLIS M18® is a friendly bacteria that can be used in conjunction with regular oral hygiene practices to establish a healthy balance of natural bacteria in the mouth to support healthy teeth and gums and overall health.
Micah Osborne, CEO at Stratum Nutrition®, "We are proud to be partnered with Blis Technologies as they continue to pursue research to provide high quality probiotic solutions. The BLIS ingredients have been a key part of our proprietary branded ingredient portfolio. We are excited to be able to build on this with the addition of dairy free BLIS K12® and BLIS M18®."
For more information about Stratum Nutrition® and its branded ingredients, please visit www.stratumnutrition.com.
###
About Stratum Nutrition
Stratum Nutrition®, a business of ESM Technologies, LLC, sustainably provides world class nutrition ingredient solutions to nutritional product formulators for human and pet health. Stratum offers a portfolio of research-supported, branded ingredients that are progressive, safe and effective, including NEM® brand eggshell membrane, ESC® brand eggshell calcium, Ahiflower® plant-based omegas-3,6,9, Curcumin 95, curQplus™, LBiome™ Lactobacillus LB postbiotic, NatAxtin™ astaxanthin, as well as oral health probiotics, BLIS K12® and BLIS M18®. These trusted ingredients are relied upon by consumers internationally. Visit www.stratumnutrition.com for more information.
More on PrAtlas
- TheOneLofi2: New Home for Chill Lo-Fi Hip Hop Beats Launches on YouTube
- eJoule Inc Participates in Silicon Dragon CES 2026
- HBZBZL Unveils "Intelligent Ecosystem" Strategy: Integrating AI Analytics with Web3 Incubation
- Kaltra Launches Next-Gen MCHEdesign With Full Integration Into MCHEselect — Instant Simulation & Seamless Microchannel Coil Workflow
- A Well-Fed World, Youth Climate Save and PAN International Launch PHRESH: A Global Directory of Plant-Based Hunger Relief Organizations
About Blis Technologies
Blis Technologies develops and manufactures the world's first advanced oral probiotics, BLIS K12® & BLIS M18®. Based out of New Zealand, Blis Technologies combine innovation with more than 30 years of research to provide delivery probiotic solutions for specific health areas including ears, nose, throat, teeth and gums, and skin care. Visit www.blis.co.nz for more information.
| *These statements have not been evaluated by the U.S. Food & Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. |
Source: Stratum Nutrition
0 Comments
Latest on PrAtlas
- "Micro-Studio": Why San Diegans are Swapping Crowded Gyms for Private, One-on-One Training at Sweat Society
- Beycome Closes $2.5M Seed Round Led by InsurTech Fund
- Tru by Hilton Columbia South Opens to Guests
- Christy Sports donates $56K in new gear to SOS Outreach to help kids hit the slopes
- "BigPirate" Sets Sail: A New Narrative-Driven Social Casino Adventure
- Phinge CEO Ranked #1 Globally by Crunchbase for the Last Week, Will Be in Las Vegas Jan. 4-9, the Week of CES to Discuss Netverse & IPO Coming in 2026
- Women's Everyday Safety Is Changing - The Blue Luna Shows How
- Microgaming Unveils Red Papaya: A New Studio Delivering Cutting-Edge, Feature-Rich Slots
- 5-Star Duncan Injury Group Expands Personal Injury Representation to Arizona
- The End of "Influencer" Gambling: Bonusetu Analyzes Finland's Strict New Casino Marketing Laws
- AI-Driven Cybersecurity Leader Gains Industry Recognition, Secures $6M Institutional Investment, Builds Momentum Toward $16M Annual Run-Rate Revenue
- TRIO Heating, Air & Plumbing Now Ranks #1 in San Jose
- Milwaukee Job Corps Center Hosts Alumni Day, Calls Alumni to Action on Open Enrollment Campaign
- Golden Paper Identifies Global Growth in Packaging Papers and Upgrades Its High-End Production Capacity
- Champagne, Caviar Bumps & Pole Performances — Welcome the New Year Early with HandPicked Social Club
- A New Soul Album: Heart Of Kwanzaa, 7-Day Celebration
- Allegiant Management Group Named 2025 Market Leader in Orlando by PropertyManagement.com
- NAFMNP Awarded USDA Cooperative Agreement to Continue MarketLink Program Under FFAB
- Costa Oil - 10 Minute Oil Change Surpasses 70 Locations with Construction of San Antonio, TX Stores — Eyes Growth Via Acquisition or Being Acquired
- LaTerra and Respark Under Contract with AIMCO to Acquire a $455M, 7-Property Chicago Multifamily Portfolio
